Core Laboratories Inc
(CLB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 20,219 | 17,432 | 16,424 | 8,207 | -97,073 |
| Depreciation Amortization | 18,516 | 14,118 | 9,622 | 4,871 | 20,867 |
| Income taxes - deferred | 6,012 | 3,058 | 2,732 | 4,704 | -12,216 |
| Accounts receivable | -13,522 | -12,135 | -10,013 | -3,180 | 46,421 |
| Accounts payable and accrued liabilities | 6,568 | 9,661 | 6,536 | 2,265 | -12,838 |
| Other Working Capital | -20,563 | -16,890 | -18,710 | -14,064 | 5,939 |
| Other Operating Activity | 19,349 | 14,181 | 10,882 | 5,184 | 106,768 |
| Operating Cash Flow | $36,579 | $29,425 | $17,473 | $7,987 | $57,868 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,861 | -8,302 | -5,381 | -2,554 | -10,146 |
| Net Acquisitions | 873 | 513 | 513 | N/A | -225 |
| Purchase Sale Intangibles | -318 | -249 | -146 | -78 | -498 |
| Other Investing Activity | 1,765 | 1,260 | 1,490 | 1,484 | 18,222 |
| Investing Cash Flow | $-10,223 | $-6,529 | $-3,378 | $-1,070 | $7,851 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 155,000 | 123,000 | 68,000 | 68,000 | 56,000 |
| Debt Repayment | -226,000 | -194,000 | -119,000 | -119,000 | -102,000 |
| Common Stock Issued | 60,000 | 60,000 | 60,000 | 60,000 | N/A |
| Common Stock Repurchased | -8,256 | -3,911 | -1,031 | -171 | -2,793 |
| Dividend Paid | -1,834 | -1,372 | -909 | -446 | -12,446 |
| Other Financing Activity | -1,369 | -1,369 | -1,344 | -1,300 | -1,766 |
| Financing Cash Flow | $-22,459 | $-17,652 | $5,716 | $7,083 | $-63,005 |
| Beginning Cash Position | 13,806 | 13,806 | 13,806 | 13,806 | 11,092 |
| End Cash Position | 17,703 | 19,050 | 33,617 | 27,806 | 13,806 |
| Net Cash Flow | $3,897 | $5,244 | $19,811 | $14,000 | $2,714 |
| Free Cash Flow | |||||
| Operating Cash Flow | 36,579 | 29,425 | 17,473 | 7,987 | 57,868 |
| Capital Expenditure | -13,539 | -8,789 | -5,657 | -2,772 | -11,880 |
| Free Cash Flow | 23,040 | 20,636 | 11,816 | 5,215 | 45,988 |